Paper21285992
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
Yun J and 10 others. Br J Cancer, 2011. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. Papers, record 21285992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21285992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Breast Neoplasms | Major topic |
| Carcinoma | Major topic |
| Hepatitis B | Major topic |
| Lamivudine | Major topic |
| Adult | |
| Aged | |
| Algorithms | |
| Anthracyclines | |
| Antibiotic Prophylaxis | |
| Antibiotics, Antineoplastic | |
| Antiviral Agents | |
| Case-Control Studies | |
| Chemotherapy, Adjuvant | |
| Combined Modality Therapy | |
| Disease Progression | |
| Female | |
| Humans | |
| Incidence | |
| Middle Aged | |
| Postoperative Complications | |
| Retrospective Studies |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14990649 | Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/14990649 | PubMed |
| 2 | 19714720 | Chronic hepatitis B: update 2009. | Hepatology | 2009 | https://conductscience.org/library/papers/19714720 | PubMed |
| 3 | 10789823 | Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. | Drug Saf | 2000 | https://conductscience.org/library/papers/10789823 | PubMed |
| 4 | 11722410 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. | Br J Haematol | 2001 | https://conductscience.org/library/papers/11722410 | PubMed |
| 5 | 16861051 | Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16861051 | PubMed |
| 6 | 12794717 | Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. | J Med Virol | 2003 | https://conductscience.org/library/papers/12794717 | PubMed |
| 7 | 12473512 | Chemotherapy for metastatic breast cancer-report of a European expert panel. | Lancet Oncol | 2002 | https://conductscience.org/library/papers/12473512 | PubMed |
| 8 | 3049953 | A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3049953 | PubMed |
| 9 | 1983820 | Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. | Gastroenterology | 1991 | https://conductscience.org/library/papers/1983820 | PubMed |
| 10 | 3618581 | Hepatitis B virus infection in Chinese families in Hong Kong. | Am J Epidemiol | 1987 | https://conductscience.org/library/papers/3618581 | PubMed |
| 11 | 20037275 | Current status of liver diseases in Korea: hepatitis B. | Korean J Hepatol | 2009 | https://conductscience.org/library/papers/20037275 | PubMed |
| 12 | 9392700 | Hepatitis B virus infection. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9392700 | PubMed |
| 13 | 8872324 | Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8872324 | PubMed |
| 14 | 15054446 | Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. | Br J Cancer | 2004 | https://conductscience.org/library/papers/15054446 | PubMed |
| 15 | 20516452 | American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20516452 | PubMed |
| 16 | 2468745 | Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2468745 | PubMed |
| 17 | 9654535 | A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9654535 | PubMed |
| 18 | 14996349 | Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. | J Viral Hepat | 2004 | https://conductscience.org/library/papers/14996349 | PubMed |
| 19 | 19077421 | Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation. | Chemotherapy | 2009 | https://conductscience.org/library/papers/19077421 | PubMed |
| 20 | 17256718 | Chronic hepatitis B. | Hepatology | 2007 | https://conductscience.org/library/papers/17256718 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42104370 | Chronic hepatitis B virus infection and the risk of extrahepatic malignancies: an updated review of epidemiology, mechanisms, and clinical implications. | Virol J | 2026 | https://conductscience.org/library/papers/42104370 | PubMed |
| 38958900 | Cross-sectional study of hepatitis B virus infection in female breast cancer patients in China for the first time diagnosed. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/38958900 | PubMed |
| 36765340 | Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma. | World J Surg Oncol | 2023 | https://conductscience.org/library/papers/36765340 | PubMed |
| 34834460 | Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. | J Pers Med | 2021 | https://conductscience.org/library/papers/34834460 | PubMed |
| 34368296 | Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. | World J Clin Cases | 2021 | https://conductscience.org/library/papers/34368296 | PubMed |
| 33311896 | Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy. | J Clin Exp Hepatol | 2020 | https://conductscience.org/library/papers/33311896 | PubMed |
| 27330792 | Analysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy. | Mol Clin Oncol | 2016 | https://conductscience.org/library/papers/27330792 | PubMed |
| 27257429 | Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened. | Hepat Mon | 2016 | https://conductscience.org/library/papers/27257429 | PubMed |
| 27121321 | Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation. | Oncotarget | 2016 | https://conductscience.org/library/papers/27121321 | PubMed |
| 26752138 | A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience. | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/26752138 | PubMed |
| 26595058 | Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis. | Ann Intern Med | 2016 | https://conductscience.org/library/papers/26595058 | PubMed |
| 26274393 | Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis. | PLoS One | 2015 | https://conductscience.org/library/papers/26274393 | PubMed |
| 26193852 | Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). | Ann Hematol | 2015 | https://conductscience.org/library/papers/26193852 | PubMed |
| 26057738 | Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis. | PLoS One | 2015 | https://conductscience.org/library/papers/26057738 | PubMed |
| 25658926 | The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system. | PLoS One | 2015 | https://conductscience.org/library/papers/25658926 | PubMed |
| 25101233 | Immunosuppression in Patients with Chronic Hepatitis B. | Curr Hepatol Rep | 2014 | https://conductscience.org/library/papers/25101233 | PubMed |
| 24247262 | Management of patients with hepatitis B who require immunosuppressive therapy. | Nat Rev Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/24247262 | PubMed |
| 24209764 | Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. | BMC Cancer | 2013 | https://conductscience.org/library/papers/24209764 | PubMed |
| 23805156 | Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis. | Hepat Mon | 2013 | https://conductscience.org/library/papers/23805156 | PubMed |
| 23652302 | Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours. | Br J Cancer | 2013 | https://conductscience.org/library/papers/23652302 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21285992
GET https://conductscience.org/api/papers/v1/21285992/references?page=2